Public health & disease milestones | Good News for Humankind

Cameroonian child, for article on malaria vaccine rollout

Cameroon’s malaria vaccine cuts child cases 20% in first year

By Peter Schulte / May 6, 2026 / Good News For Humankind

Cameroon’s malaria vaccine rollout delivered something remarkable in its first year: nearly 67,000 fewer malaria cases among children under five across 42 high-burden districts, a 20% drop compared to 2023. The country was one of 13 across Africa to fold the long-awaited vaccine into routine childhood immunization in 2024, part of a coordinated regional push that delivered more than 18 million doses. Among the first to be vaccinated were twins born in January 2024, whose mother says simply that they have never had malaria. After three decades of development and years of pilot studies, a tool once considered out of reach is now protecting children at scale — and the early evidence suggests it is working.

HIV up close, for article on mother-to-child HIV transmission

The Bahamas officially eliminates mother-to-child transmission of HIV

By Peter Schulte / April 30, 2026 / Good News For Humankind

The Bahamas just became the 12th country or territory in the Americas certified by the World Health Organization for eliminating mother-to-child HIV transmission — meaning babies born there now enter the world free of the virus by design, not by luck. The country built this through a quietly powerful idea: every pregnant woman, regardless of nationality or legal status, gets HIV screening at her first prenatal visit and again later in pregnancy, with treatment and follow-up offered free. Reaching that standard across more than 700 scattered islands took years of coordination between nurses, doctors, and public clinics. More than half of all places worldwide to achieve this milestone are now in Latin America and the Caribbean — proof that with universal care and political will, this victory is replicable anywhere.

Scientist filling tubes, for article on reversible male contraception

Cornell researchers achieve first reversible male birth control in mice

By Peter Schulte / April 30, 2026 / Good News For Humankind

Reversible male birth control just cleared a major hurdle: in a new Cornell study, male mice stopped producing sperm entirely after three weeks of treatment, then bounced back to full fertility within six weeks of stopping. The approach skips hormones altogether, targeting a specific window of sperm development in the testis so libido and other traits stay untouched. Even better, the mice went on to father healthy pups who were themselves fertile. The researchers are now testing new molecular targets and hope to launch a company within two years to move toward human trials. If the science holds up across species, it could finally give men a real long-acting option — and ease a contraceptive burden women have shouldered alone for generations.

People holding breast cancer pin, for article on vitamin D breast cancer

Brazilian researchers find vitamin D boosts breast cancer chemo by 79%

By Peter Schulte / April 29, 2026 / Good News For Humankind

Vitamin D may give breast cancer chemotherapy a meaningful boost, according to a new Brazilian trial in which 43% of women taking a daily supplement saw their tumors disappear completely, compared to 24% on a placebo. Researchers at São Paulo State University gave 80 patients a modest 2,000 IU dose alongside their standard pre-surgery chemo — a level safe enough for everyday use and cheap enough for almost anyone. Most women in the study were vitamin D-deficient to begin with, a pattern common in cancer patients worldwide. If larger trials confirm the finding, it points to something rare and hopeful in oncology: a low-cost, low-risk addition that could improve outcomes most for the communities currently facing the steepest deficiency rates and the hardest cancer journeys.

African children smiling, for article on measles vaccination Africa

Nearly 20 million measles deaths averted in Africa since 2000

By Peter Schulte / April 22, 2026 / Good News For Humankind

Measles vaccines in Africa have prevented an estimated 19.5 million deaths since 2000 — roughly 800,000 lives saved every year for nearly a quarter century. A new WHO and Gavi analysis credits steady investment in cold-chain systems, community health workers, and political will, with coverage for the critical second measles dose climbing more than tenfold over that stretch. This year, Cabo Verde, Mauritius, and Seychelles became the first sub-Saharan nations to officially eliminate measles and rubella, a milestone once considered out of reach. The story is a powerful reminder that global health progress, though uneven, compounds quietly over decades — and that protecting children anywhere strengthens the case for protecting them everywhere.

Medical researcher in a lab examining vials related to asthma and COPD treatment and mRNA vaccine development, for article on benralizumab injection, for article on mRNA lung cancer vaccine

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

By / April 19, 2026 / Good News For Humankind

Benralizumab, a single injection given during an asthma or COPD attack, outperformed the steroid pills that have been the only emergency option since the 1970s. In a King’s College London trial of 158 patients, those who got the shot had four times fewer treatment failures over 90 days, along with easier breathing and fewer follow-up visits. Because steroids carry real risks with repeated use — diabetes, osteoporosis, and more — a genuine alternative could change daily life for millions of people who live in fear of the next flare-up. After a half-century of stalled progress on diseases that claim 3.8 million lives a year, this feels like the door finally opening.

A nurse in a rural Mexican clinic checks a patient's blood pressure, for an article about Mexico universal healthcare

Mexico launches universal healthcare for all 133 million citizens

By Peter Schulte / April 17, 2026 / Good News For Humankind

Mexico universal healthcare is now officially a reality, with the country launching a system designed to cover all 133 million citizens through the restructured IMSS-Bienestar network. Before this reform, an estimated 50 million Mexicans had no formal health insurance, with rural and Indigenous communities bearing the heaviest burden of untreated illness and medical debt. The new system severs the long-standing tie between employment and healthcare access, providing free consultations, medicines, and hospital services regardless of income. If implemented effectively, Mexico’s move could serve as a powerful model for other middle-income nations still navigating fragmented, inequitable health systems.

A person sitting quietly on a bench at sunset, for an article about global suicide rate decline — 15 words.

Global suicide rate has dropped nearly 40% since the 1990s

By Peter Schulte / April 10, 2026 / Good News For Humankind

Global suicide rates have dropped nearly 40% since the early 1990s, falling from roughly 15 deaths per 100,000 people to around nine — one of modern public health’s most significant and underreported victories. This decline was driven by expanded mental health services, crisis intervention programs, and proven strategies like restricting access to lethal means. The progress spans dozens of countries, with especially sharp declines in East Asia and Europe. Critically, this trend demonstrates that suicide is preventable at a population level — making the case for sustained investment in mental health infrastructure worldwide.

A researcher examining cancer cell slides under a microscope for an article about UK cancer death rates

U.K. cancer death rates reach their lowest level ever recorded

By Peter Schulte / April 7, 2026 / Good News For Humankind

Cancer death rates in the United Kingdom have fallen to the lowest level ever recorded, according to Cancer Research UK data published in 2026. Age-standardized mortality rates have dropped by more than 25% over the past two decades, driven by advances in lung, bowel, and breast cancer treatment and diagnosis. Expanded NHS screening programs, immunotherapy, and targeted drug therapies are credited as key factors behind the sustained decline. The achievement represents generations of compounding progress across research, clinical care, and public health, though significant inequalities in cancer survival persist across socioeconomic and geographic lines.

A healthcare worker conducting a prenatal consultation for an article about mother-to-child HIV transmission

Denmark becomes first E.U. nation to end mother-to-child transmission of HIV and syphilis

By Peter Schulte / March 16, 2026 / Good News For Humankind

Denmark has eliminated mother-to-child transmission of both HIV and syphilis, becoming the first European Union country to receive WHO validation for this dual achievement. Every pregnant person in Denmark receives routine screening for both infections, with treatment integrated directly into antenatal care through a universal health system that removes financial barriers. Left untreated, HIV carries a transmission risk of up to 45 percent during pregnancy and birth, while untreated syphilis causes stillbirth and severe newborn complications. Denmark’s success proves elimination is possible with the right infrastructure and political commitment, even as congenital syphilis rises sharply in countries like the United States.